Wuhan General Correlations
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Wuhan General Correlation With Market
Significant diversification
The correlation between Wuhan General Gr and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan General Gr and DJI in the same portfolio, assuming nothing else is changed.
Wuhan |
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
Moving together with Wuhan Pink Sheet
| 0.67 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.69 | CLVRW | Clever Leaves Holdings | PairCorr |
| 0.61 | GLGLF | GLG Life Tech | PairCorr |
| 0.72 | OASMY | Oasmia Pharmaceutical | PairCorr |
| 0.64 | DYNT | Dynatronics | PairCorr |
| 0.74 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
| 0.72 | KDLYW | Kindly MD, Warrants | PairCorr |
Moving against Wuhan Pink Sheet
| 0.8 | YCBD-PA | cbdMD Inc | PairCorr |
| 0.75 | HROWM | Harrow Health, 11875 | PairCorr |
| 0.72 | INIS | International Isotopes | PairCorr |
| 0.58 | PETQ | PetIQ Inc | PairCorr |
| 0.54 | ELTP | Elite Pharma | PairCorr |
| 0.38 | VAXX | Vaxxinity | PairCorr |
| 0.8 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.78 | ATR | AptarGroup | PairCorr |
| 0.71 | BTSGU | BrightSpring Health | PairCorr |
| 0.61 | FRTX | Fresh Tracks Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Wuhan Pink Sheet performing well and Wuhan General Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Wuhan General's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BIOIF | 22.01 | 7.98 | 0.17 | (1.07) | 13.70 | 108.11 | 279.73 | |||
| HCANF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| LOVFF | 2.31 | (0.22) | 0.00 | (5.74) | 0.00 | 7.41 | 36.67 | |||
| AVCNF | 4.75 | (0.19) | 0.00 | (1.05) | 0.00 | 17.39 | 44.00 | |||
| BBRRF | 7.99 | 0.96 | 0.06 | (0.44) | 8.03 | 22.00 | 65.56 | |||
| CBWTF | 4.93 | (0.31) | 0.00 | (0.12) | 0.00 | 10.34 | 26.29 | |||
| FLWPF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AUSAF | 298.46 | 152.08 | 0.00 | (9.76) | 0.00 | 0.00 | 10,099 | |||
| ACRDF | 7.89 | (0.04) | 0.00 | 0.13 | 0.00 | 21.43 | 75.71 |
View Wuhan General Related Equities
| Risk & Return | Correlation |
Wuhan General Corporate Management
| Anna Morera | Chief Medical Officer | Profile | |
| Carol Pan | Principal Officer | Profile | |
| Luka MSc | Director Communication | Profile | |
| Huang Zhaoqi | Vice Director | Profile | |
| Johann Mcloughlin | Head Design | Profile | |
| Shivani Subudhi | Head Marketing | Profile | |
| Willem Jonker | Chief Officer | Profile |
Still Interested in Wuhan General Gr?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.